MERRIMACK PHARMACEUTICALS INC Stock-Based Compensation
MERRIMACK PHARMACEUTICALS INC reported Stock-Based Compensation of $10.73 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2014-03-04
- MERRIMACK PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2013-12-31 was $2.78M, a 42.05% increase year-over-year.
- MERRIMACK PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2013-09-30 was $2.54M, a 16.22% increase year-over-year.
- MERRIMACK PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2013-06-30 was $3.03M, a 114.89% increase year-over-year.
- MERRIMACK PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2013-03-31 was $2.39M, a 78.19% increase year-over-year.
- MERRIMACK PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2013 was $10.73M, a 55.80% increase from fiscal 2012.
- MERRIMACK PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2012 was $6.89M, a 0.91% decline from fiscal 2011.
- MERRIMACK PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2011 was $6.95M, a 52.76% increase from fiscal 2010.
- MERRIMACK PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2010 was $4.55M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2013-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $5.32M derived: sum of 2 quarters · filed 2014-03-04 | $8.35M derived: sum of 3 quarters · filed 2014-03-04 | $10.73M 10-K · filed 2014-03-04 |
| 2013-09-30 | $2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $5.57M derived: sum of 2 quarters · filed 2013-11-08 | $7.95M 10-Q · filed 2013-11-08 | $9.91M derived: sum of 4 quarters · filed 2014-03-04 |
| 2013-06-30 | $3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $5.42M 10-Q · filed 2013-08-08 | $7.37M derived: sum of 3 quarters · filed 2014-03-04 | $9.56M derived: sum of 4 quarters · filed 2014-03-04 |
| 2013-03-31 | $2.39M 10-Q · filed 2013-05-13 | $4.34M derived: sum of 2 quarters · filed 2014-03-04 | $6.53M derived: sum of 3 quarters · filed 2014-03-04 | $7.94M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $4.14M derived: sum of 2 quarters · filed 2014-03-04 | $5.55M derived: sum of 3 quarters · filed 2014-03-04 | $6.89M 10-K · filed 2014-03-04 |
| 2012-09-30 | $2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $3.59M derived: sum of 2 quarters · filed 2013-11-08 | $4.93M 10-Q · filed 2013-11-08 | $6.31M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $2.75M 10-Q · filed 2013-08-08 | $4.13M derived: sum of 3 quarters · filed 2014-03-04 | $5.92M derived: sum of 4 quarters · filed 2014-03-04 |
| 2012-03-31 | $1.34M 10-Q · filed 2013-05-13 | $2.72M derived: sum of 2 quarters · filed 2014-03-04 | $4.51M derived: sum of 3 quarters · filed 2014-03-04 | $7.27M derived: sum of 4 quarters · filed 2014-03-04 |
| 2011-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $3.17M derived: sum of 2 quarters · filed 2014-03-04 | $5.93M derived: sum of 3 quarters · filed 2014-03-04 | $6.95M 10-K · filed 2014-03-04 |
| 2011-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $4.55M derived: sum of 2 quarters · filed 2012-11-14 | $5.57M 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $3.78M 10-Q · filed 2012-08-14 | ||
| 2011-03-31 | $1.02M 10-Q · filed 2012-05-15 | |||
| 2010-12-31 | $4.55M 10-K · filed 2013-03-20 |